Selection of an adjuvant for vaccination with the malaria antigen, MSA-2

By Pye D.   Vandenberg K.L.   Dyer S.L.   Irving D.O.   Goss N.H.   Woodrow G.C.   Saul A.   Alving C.R.   Richards R.L.   Ballou W.R.   Wu M.-J.   Skoff K.   Anders R.F.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 1017-1023

Elsevier

Access to resources Recommend Favorite

Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus

By Shutong Y.   Carroll M.W.   Torres-Duarte A.P.   Moss B.   Davidson E.A.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1303-1313

Elsevier

Access to resources Recommend Favorite

Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii

By Supply P.   Sutton P.   Coughlan S.N.   Bilo K.   Saman E.   Trees A.J.   Cesbron Delauw M.-F.   Locht C.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 705-714

Elsevier

Access to resources Recommend Favorite

Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin

By Christodoulides M.   Rattue E.   Heckels J.E.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 131-139

Elsevier

Access to resources Recommend Favorite

Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum

By Zheng C.   Xie P.   Chen Y.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 914-919

Elsevier

Access to resources Recommend Favorite